Perjeta/Herceptin (pertuzumab/trastuzumab)

pCPA File Number: 20767
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Breast Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: